Chi-Un Pae | Psychiatrist.com

Letter to the Editor

Augmentation of Dopaminergic Agents for Major Depressive Disorder

Commentary

Cognitive Dysfunction in Psychiatric Illness: A Neglected Domain

Original Research

Effects of Olanzapine on Prolactin Levels of Female Patients With Schizophrenia Treated With Risperidone

Original Research

Rapid Versus Conventional Initiation of Quetiapine in the Treatment of Schizophrenia: A Randomized, Parallel-Group Trial

Original Research

Safety of Selegiline Transdermal System in Clinical Practice: Analysis of Adverse Events From Postmarketing Exposures

Original Research

History of Depressive and Anxiety Disorders and Paroxetine Response in Patients With Irritable Bowel Syndrome: Post Hoc Analysis From a Placebo-Controlled Study

Original Research

An Open-Label, Rater-Blinded, Flexible-Dose, 8-Week Trial of Escitalopram in Patients With Major Depressive Disorder With Atypical Features

Article

A Double-Blind, Placebo-Controlled, Parallel-Group Pilot Study of Milnacipran for Chronic Radicular Pain (Sciatica) Associated With Lumbosacral Disc Disease

Here, review results from a 10-week study that compared the pain-relieving effects of milnacipran, an SNRI, to that of placebo in patients with lumbosacral disc disease. Nerve pain in...